Kayne Anderson Rudnick Investment Management LLC Genmab A/S Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$27.94 - $35.44 $321,729 - $408,091	-11,515 Reduced 10.59%	97,218 $3.1 Million
Q3 2023 Nov 13, 2023	SELL	$35.27 - $42.24 $8,993 - $10,771	-255 Reduced 0.23%	108,733 $3.84 Million
Q2 2023 Aug 11, 2023	BUY	$37.4 - $42.94 $103,074 - $118,342	2,756 Added 2.59%	108,988 $4.14 Million
Q1 2023 May 16, 2023	SELL	$34.88 - $43.22 $65,818 - $81,556	-1,887 Reduced 1.75%	106,232 $4.01 Million
Q4 2022 Feb 13, 2023	SELL	$33.8 - $47.06 $163,963 - $228,288	-4,851 Reduced 4.29%	108,119 $4.58 Million
Q3 2022 Nov 16, 2022	BUY	$31.52 - $373.61 $3.56 Million - $42.2 Million	112,970 New	112,970 $3.63 Million
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $3.64 Million - $43.1 Million	-115,329 Closed	0 $3.63 Million
Q2 2022 Aug 12, 2022	SELL	$26.83 - $38.57 $114,429 - $164,501	-4,265 Reduced 3.57%	115,329 $3.75 Million
Q1 2022 May 16, 2022	SELL	$30.95 - $39.68 $699,253 - $896,490	-22,593 Reduced 15.89%	119,594 $4.33 Million
Q4 2021 Feb 14, 2022	SELL	$35.87 - $47.12 $66,467 - $87,313	-1,853 Reduced 1.29%	142,187 $5.63 Million
Q3 2021 Nov 12, 2021	BUY	$41.55 - $48.72 $298,038 - $349,468	7,173 Added 5.24%	144,040 $6.3 Million
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $137,635 - $186,570	4,186 Added 3.15%	136,867 $5.59 Million
Q1 2021 May 17, 2021	BUY	$30.92 - $44.4 $140,407 - $201,620	4,541 Added 3.54%	132,681 $4.36 Million
Q4 2020 Feb 12, 2021	SELL	$33.66 - $40.76 $528,630 - $640,135	-15,705 Reduced 10.92%	128,140 $5.21 Million
Q3 2020 Nov 16, 2020	BUY	$33.07 - $38.68 $110,023 - $128,688	3,327 Added 2.37%	143,845 $5.27 Million
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $277,552 - $469,139	13,843 Added 10.93%	140,518 $4.76 Million
Q1 2020 May 15, 2020	SELL	$17.15 - $25.22 $8,815 - $12,963	-514 Reduced 0.4%	126,675 $2.68 Million
Q4 2019 Feb 13, 2020	BUY	$18.88 - $24.14 $22,089 - $28,243	1,170 Added 0.93%	127,189 $2.84 Million
Q3 2019 Nov 14, 2019	BUY	$18.0 - $21.38 $2.27 Million - $2.69 Million	126,019 New	126,019 $2.55 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account